VYOME HOLDINGS, INC. Selling, General and Administrative Expense
VYOME HOLDINGS, INC. (HIND) reported Selling, General and Administrative Expense of $364.89 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2026-08-12
- VYOME HOLDINGS, INC. selling, general and administrative expense for the quarter ending 2026-06-30 was $364.89K, a 37.49% increase year-over-year.
- VYOME HOLDINGS, INC. selling, general and administrative expense for the quarter ending 2026-03-31 was $477.57K, a 83.95% increase year-over-year.
- VYOME HOLDINGS, INC. selling, general and administrative expense for the quarter ending 2025-12-31 was $996.20K, a 302.71% increase year-over-year.
- VYOME HOLDINGS, INC. selling, general and administrative expense for the quarter ending 2025-09-30 was $844.34K, a 242.09% increase year-over-year.
- VYOME HOLDINGS, INC. selling, general and administrative expense for fiscal 2025 was $2.37M, a 163.26% increase from fiscal 2024.
- VYOME HOLDINGS, INC. selling, general and administrative expense for fiscal 2024 was $898.57K, a 88.10% decline from fiscal 2023.
- VYOME HOLDINGS, INC. selling, general and administrative expense for fiscal 2023 was $7.55M, a 46.44% decline from fiscal 2022.
- VYOME HOLDINGS, INC. selling, general and administrative expense for fiscal 2022 was $14.09M, a 58.47% increase from fiscal 2021.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 3 month as first filed | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 6 month as first filed | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 9 month as first filed | Selling, General and Administrative Expense 12 month | Selling, General and Administrative Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $364.89K 10-Q · filed 2026-08-12 | $842.47K 10-Q · filed 2026-08-12 | $1.84M derived: sum of 3 quarters · filed 2026-08-12 | $2.68M derived: sum of 4 quarters · filed 2026-08-12 | ||||
| 2026-03-31 | $477.57K 10-Q · filed 2026-05-12 | $1.47M derived: sum of 2 quarters · filed 2026-05-12 | $2.32M derived: sum of 3 quarters · filed 2026-05-12 | $2.58M derived: sum of 4 quarters · filed 2026-08-12 | ||||
| 2025-12-31 | $996.20K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | $1.84M derived: sum of 2 quarters · filed 2026-03-18 | $2.11M derived: sum of 3 quarters · filed 2026-08-12 | $2.37M 10-K · filed 2026-03-18 | ||||
| 2025-09-30 | $844.34K 10-Q · filed 2025-11-14 | $1.11M derived: sum of 2 quarters · filed 2026-08-12 | $1.37M 10-Q · filed 2025-11-14 | $1.62M derived: sum of 4 quarters · filed 2026-08-12 | ||||
| 2025-06-30 | $265.39K 10-Q · filed 2026-08-12 | $525.02K 10-Q · filed 2026-08-12 | $525.02K 8-K · filed 2025-09-02 | $772.40K derived: sum of 3 quarters · filed 2026-08-12 | $1.02M derived: sum of 4 quarters · filed 2026-08-12 | |||
| 2025-03-31 | $259.63K 10-Q · filed 2026-05-12 | $507.00K derived: sum of 2 quarters · filed 2026-05-12 | $753.82K derived: sum of 3 quarters · filed 2026-05-12 | $1.42M derived: sum of 4 quarters · filed 2026-05-12 | ||||
| 2024-12-31 | $247.38K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | $494.20K derived: sum of 2 quarters · filed 2026-03-18 | $1.16M derived: sum of 3 quarters · filed 2026-03-18 | $898.57K 10-K · filed 2026-03-18 | ||||
| 2024-09-30 | $246.82K 10-Q · filed 2025-11-14 | $719.00K 10-Q · filed 2024-11-14 | $916.82K derived: sum of 2 quarters · filed 2025-11-14 | $651.20K 10-Q · filed 2025-11-14 | $2.41M 10-Q · filed 2024-11-14 | $3.33M derived: sum of 4 quarters · filed 2025-11-14 | ||
| 2024-06-30 | $670.00K 10-Q · filed 2024-08-14 | $404.38K 8-K · filed 2025-09-02 | $1.69M 10-Q · filed 2024-08-14 | $3.09M derived: sum of 3 quarters · filed 2024-08-14 | $4.88M derived: sum of 4 quarters · filed 2024-11-14 | |||
| 2024-03-31 | $1.02M 10-Q · filed 2024-05-15 | $2.42M derived: sum of 2 quarters · filed 2024-05-15 | $4.21M derived: sum of 3 quarters · filed 2024-11-14 | $6.38M derived: sum of 4 quarters · filed 2024-11-14 | ||||
| 2023-12-31 | $1.40M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $3.19M derived: sum of 2 quarters · filed 2024-11-14 | $5.37M derived: sum of 3 quarters · filed 2024-11-14 | $7.55M 10-K · filed 2024-04-01 | ||||
| 2023-09-30 | $1.79M 10-Q · filed 2024-11-14 | $3.97M derived: sum of 2 quarters · filed 2024-11-14 | $6.15M 10-Q · filed 2024-11-14 | $8.31M derived: sum of 4 quarters · filed 2024-11-14 | ||||
| 2023-06-30 | $2.18M 10-Q · filed 2024-08-14 | $4.36M 10-Q · filed 2024-08-14 | $6.52M derived: sum of 3 quarters · filed 2024-08-14 | $9.12M derived: sum of 4 quarters · filed 2024-08-14 | ||||
| 2023-03-31 | $2.18M 10-Q · filed 2024-05-15 | $4.34M derived: sum of 2 quarters · filed 2024-05-15 | $6.94M derived: sum of 3 quarters · filed 2024-05-15 | $11.58M derived: sum of 4 quarters · filed 2024-05-15 | ||||
| 2022-12-31 | $2.16M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $4.76M derived: sum of 2 quarters · filed 2024-04-01 | $9.40M derived: sum of 3 quarters · filed 2024-04-01 | $14.09M 10-K · filed 2024-04-01 | ||||
| 2022-09-30 | $2.60M 10-Q · filed 2023-11-09 | $2.62M 10-Q · filed 2022-11-14 | $7.24M derived: sum of 2 quarters · filed 2023-11-09 | $11.94M 10-Q · filed 2023-11-09 | $11.99M 10-Q · filed 2022-11-14 | $14.89M derived: sum of 4 quarters · filed 2023-11-09 | ||
| 2022-06-30 | $4.64M 10-Q · filed 2023-08-07 | $4.66M 10-Q · filed 2022-08-19 | $9.33M 10-Q · filed 2023-08-07 | $9.37M 10-Q · filed 2022-08-19 | $12.29M derived: sum of 3 quarters · filed 2023-08-07 | $15.53M derived: sum of 4 quarters · filed 2023-08-07 | ||
| 2022-03-31 | $4.69M 10-Q · filed 2023-05-15 | $4.71M 10-Q · filed 2022-05-23 | $7.65M derived: sum of 2 quarters · filed 2023-05-15 | $10.90M derived: sum of 3 quarters · filed 2023-05-15 | $12.34M derived: sum of 4 quarters · filed 2023-05-15 | |||
| 2021-12-31 | $2.96M derived: 10-K 12 month − 10-K 9 month · filed 2023-04-17 | $6.20M derived: sum of 2 quarters · filed 2023-04-17 | $7.64M derived: sum of 3 quarters · filed 2023-04-17 | $8.89M 10-K · filed 2023-04-17 | $9.16M 10-K · filed 2022-04-08 | |||
| 2021-09-30 | $3.25M 10-K · filed 2023-04-17 | $3.50M 10-Q · filed 2021-11-12 | $4.69M derived: sum of 2 quarters · filed 2023-04-17 | $5.94M 10-K · filed 2023-04-17 | $6.19M 10-Q · filed 2021-11-12 | $7.18M derived: sum of 4 quarters · filed 2023-04-17 | ||
| 2021-06-30 | $1.44M 10-Q · filed 2022-08-19 | $2.69M 10-Q · filed 2022-08-19 | $3.94M derived: sum of 3 quarters · filed 2022-08-19 | $5.10M derived: sum of 4 quarters · filed 2022-08-19 | ||||
| 2021-03-31 | $1.25M 10-Q · filed 2022-05-23 | $4.06M 10-Q · filed 2021-05-12 | $2.50M derived: sum of 2 quarters · filed 2022-05-23 | $3.66M derived: sum of 3 quarters · filed 2022-05-23 | $4.49M derived: sum of 4 quarters · filed 2022-05-23 | |||
| 2020-12-31 | $1.25M derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-08 | $2.41M derived: sum of 2 quarters · filed 2022-04-08 | $3.24M derived: sum of 3 quarters · filed 2022-04-08 | $4.69M 10-K · filed 2022-04-08 | $8.78M 10-K · filed 2021-03-12 | |||
| 2020-09-30 | $1.16M 10-Q · filed 2021-11-12 | $1.29M 10-Q · filed 2020-11-06 | $1.99M derived: sum of 2 quarters · filed 2021-11-12 | $3.45M 10-Q · filed 2021-11-12 | $7.55M 10-Q · filed 2020-11-06 | $9.53M derived: sum of 4 quarters · filed 2021-11-12 | ||
| 2020-06-30 | $831.00K 10-Q · filed 2021-08-16 | $2.36M 10-Q · filed 2020-07-30 | $2.29M 10-Q · filed 2021-08-16 | $6.25M 10-Q · filed 2020-07-30 | $8.37M derived: sum of 3 quarters · filed 2021-08-16 | $10.86M derived: sum of 4 quarters · filed 2021-08-16 | ||
| 2020-03-31 | $3.89M 10-Q · filed 2021-05-12 | $7.54M derived: sum of 2 quarters · filed 2021-05-12 | $10.03M derived: sum of 3 quarters · filed 2021-05-12 | $14.36M derived: sum of 4 quarters · filed 2021-05-12 | ||||
| 2019-12-31 | $3.64M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | $6.13M derived: sum of 2 quarters · filed 2021-03-12 | $10.46M derived: sum of 3 quarters · filed 2021-03-12 | $16.67M 10-K · filed 2021-03-12 | ||||
| 2019-09-30 | $2.49M 10-Q · filed 2020-11-06 | $6.82M derived: sum of 2 quarters · filed 2020-11-06 | $13.03M 10-Q · filed 2020-11-06 | $19.88M derived: sum of 4 quarters · filed 2020-11-06 | ||||
| 2019-06-30 | $4.33M 10-Q · filed 2020-07-30 | $10.54M 10-Q · filed 2020-07-30 | $17.39M derived: sum of 3 quarters · filed 2020-07-30 | $23.23M derived: sum of 4 quarters · filed 2020-07-30 | ||||
| 2019-03-31 | $6.20M 10-Q · filed 2020-06-19 | $13.06M derived: sum of 2 quarters · filed 2020-06-19 | $18.89M derived: sum of 3 quarters · filed 2020-06-19 | $26.14M derived: sum of 4 quarters · filed 2020-06-19 | ||||
| 2018-12-31 | $6.85M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $12.69M derived: sum of 2 quarters · filed 2020-02-27 | $19.94M derived: sum of 3 quarters · filed 2020-02-27 | $29.95M 10-K · filed 2020-02-27 | ||||
| 2018-09-30 | $5.84M 10-Q · filed 2019-11-08 | $13.09M derived: sum of 2 quarters · filed 2019-11-08 | $23.09M 10-Q · filed 2019-11-08 | $32.31M derived: sum of 4 quarters · filed 2019-11-08 | ||||
| 2018-06-30 | $7.25M 10-Q · filed 2019-07-24 | $17.26M 10-Q · filed 2019-07-24 | $26.48M derived: sum of 3 quarters · filed 2019-07-24 | $34.29M derived: sum of 4 quarters · filed 2019-07-24 | ||||
| 2018-03-31 | $10.01M 10-Q · filed 2019-05-10 | $19.23M derived: sum of 2 quarters · filed 2019-05-10 | $27.04M derived: sum of 3 quarters · filed 2019-05-10 | $32.90M derived: sum of 4 quarters · filed 2019-05-10 | ||||
| 2017-12-31 | $9.22M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-22 | $17.04M derived: sum of 2 quarters · filed 2019-02-22 | $22.89M derived: sum of 3 quarters · filed 2019-02-22 | $28.83M 10-K · filed 2019-02-22 | ||||
| 2017-09-30 | $7.81M 10-Q · filed 2018-11-02 | $13.67M derived: sum of 2 quarters · filed 2018-11-02 | $19.61M 10-Q · filed 2018-11-02 | $24.44M derived: sum of 4 quarters · filed 2018-11-02 | ||||
| 2017-06-30 | $5.85M 10-Q · filed 2018-08-02 | $11.79M 10-Q · filed 2018-08-02 | $16.62M derived: sum of 3 quarters · filed 2018-08-02 | $19.04M derived: sum of 4 quarters · filed 2018-08-02 | ||||
| 2017-03-31 | $5.94M 10-Q · filed 2018-05-10 | $10.77M derived: sum of 2 quarters · filed 2018-05-10 | $13.18M derived: sum of 3 quarters · filed 2018-05-10 | $14.78M derived: sum of 4 quarters · filed 2018-05-10 | ||||
| 2016-12-31 | $4.83M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-05 | $7.24M derived: sum of 2 quarters · filed 2018-03-05 | $8.84M derived: sum of 3 quarters · filed 2018-03-05 | $10.22M 10-K · filed 2018-03-05 | ||||
| 2016-09-30 | $2.41M 10-Q · filed 2017-11-03 | $4.01M derived: sum of 2 quarters · filed 2017-11-03 | $5.39M 10-Q · filed 2017-11-03 | $6.58M derived: sum of 4 quarters · filed 2018-03-05 | ||||
| 2016-06-30 | $1.60M 10-Q · filed 2017-08-02 | $2.98M 10-Q · filed 2017-08-02 | $4.17M derived: sum of 3 quarters · filed 2018-03-05 | $4.79M derived: sum of 4 quarters · filed 2018-03-05 | ||||
| 2016-03-31 | $1.38M 10-Q · filed 2017-05-10 | $2.57M derived: sum of 2 quarters · filed 2018-03-05 | $3.19M derived: sum of 3 quarters · filed 2018-03-05 | |||||
| 2015-12-31 | $1.19M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-05 | $1.81M derived: sum of 2 quarters · filed 2018-03-05 | $3.49M 10-K · filed 2018-03-05 | |||||
| 2015-09-30 | $618.00K 10-Q · filed 2016-11-10 | $2.30M 10-Q · filed 2016-11-10 | ||||||
| 2014-12-31 | $4.70M 10-K · filed 2017-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |